The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
A Review of Poloxamer 407 Pharmaceutical and Pharmacological Characteristics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Handbook of Pharmaceutical Excipients
Rowe, R. C., Sheskey, P. J., & Quinn, M. E. (1994) · Cited by 3,493
Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 2×
“It is possible to easily prepare 20Y30% (w/w) Poloxamer 407 while 35% (w/w) concentration requires placing the Poloxamer 407 solution in a freezer for a few minutes to liquefy the preparation (6,9,12).”
BackgroundMethodSolubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415
In situ-forming hydrogels--review of temperature-sensitive systems
Ruel-Gariépy, E., & Leroux, J.-C. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.019 · Cited by 1,297 · cited 2×
“, cellulose derivatives, xyloglycan, chitosan), N-isopropylacrylamide and poloxamers have commonly been quoted in the literature (1).”
BackgroundRedhead, H. M., Davis, S. S., & Illum, L. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00367-9 · Cited by 419
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
Moghimi, S. M., & Hunter, A. C. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01485-2 · Cited by 392
Danson, S., Ferry, D., Alakhov, V, Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., & Ranson, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601856 · Cited by 382
Pluronic® block copolymers: novel functional molecules for gene therapy
Kabanov, A. V., Lemieux, P., Vinogradov, S., & Alakhov, V. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00018-2 · Cited by 375
Rheological evaluation of poloxamer as an in situ gel for ophthalmic use
Edsman, K., Carlfors, J., & Petersson, R. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)00075-4 · Cited by 331
In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate
El-Kamel, A. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00234-x · Cited by 320
A Study of the Temperature-Dependent Micellization of Pluronic F127
Bohorquez, M., Koch, C., Trygstad, T., & Pandit, N. (1999) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1999.6273 · Cited by 320
Cabana, A., Aı̈t-Kadi, A., & Juhász, J. (1997) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1997.4880 · Cited by 267
Sustained release of lidocaine from Poloxamer 407 gels
Ricci, E. J., Lunardi, L. O., Nanclares, D. M. A., & Marchetti, J. M. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.09.028 · Cited by 261
Wei, G., Xu, H., Ding, P. T., Li, S. M., & Zheng, J. M. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00175-x · Cited by 248
Absorption of insulin from Pluronic F-127 gels following subcutaneous administration in rats
Barichello, J. M., Morishita, M., Takayama, K., & Nagai, T. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00119-2 · Cited by 235
Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions
Chang, J. Y., Oh, Y.-K., Choi, H.-G., Kim, Y. B., & Kim, C.-K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00232-6 · Cited by 227
Yong, C. S., Choi, J. S., Quan, Q.-Z., Rhee, J.-D., Kim, C.-K., Lim, S.-J., Kim, K.-M., Oh, P.-S., & Choi, H.-G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00809-2 · Cited by 221
Pandit, N., Trygstad, T., Croy, S., Bohorquez, M., & Koch, C. (2000) · Journal of Colloid and Interface Science · doi:10.1006/jcis.1999.6628 · Cited by 216
A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle
Lemieux, P., Guérin, N., Paradis, G., Proulx, R., Chistyakova, L., Kabanov, A., & Alakhov, V (2000) · Gene Therapy · doi:10.1038/sj.gt.3301189 · Cited by 213
ATTWOOD, D., COLLETT, J., & TAIT, C. (1985) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(85)90197-8 · Cited by 204
Miyazaki, S., Suzuki, S., Kawasaki, N., Endo, K., Takahashi, A., & Attwood, D. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00825-0 · Cited by 198
Controlled release of vancomycin from Poloxamer 407 gels
Veyries, M. L., Couarraze, G., Geiger, S., Agnely, F., Massias, L., Kunzli, B., Faurisson, F., & Rouveix, B. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00307-5 · Cited by 197
Self-citationGilbert, J. C., Richardson, J. L., Davies, M. C., Palin, K. J., & Hadgraft, J. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90002-2 · Cited by 197
Desai, S. D., & Blanchard, J. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970090e · Cited by 177
Synthesis and Characterization of Self-Assembling Block Copolymers Containing Bioadhesive End Groups
Huang, K., Lee, B. P., Ingram, D. R., & Messersmith, P. B. (2002) · Biomacromolecules · doi:10.1021/bm015650p · Cited by 175
Porter, C. J. H., Moghimi, S. M., Illum, L., & Davis, S. S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80655-z · Cited by 173
Johnston, T. P., Punjabi, M. A., & Froelich, C. J. (1992) · Pharmaceutical Research · doi:10.1023/a:1015815624334 · Cited by 167
Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold
Saim, A. B., Cao, Y., Weng, Y., Chang, C., Vacanti, M. A., Vacanti, C. A., & Eavey, R. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200010000-00023 · Cited by 166
Moore, T., Croy, S., Mallapragada, S., & Pandit, N. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00215-7 · Cited by 164
Controlled-Release Delivery System for the α-MSH Analog Melanotan-I Using Poloxamer 407
Bhardwaj, R., & Blanchard, J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960097g · Cited by 160
Ryu, J., Chung, S.-J., Lee, M.-H., Kim, C., & Shim, C. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00189-8 · Cited by 152
Stolnik, S., Daudali, B., Ariën, A., Whetstone, J., Heald, C. R., Garnett, M. C., Davis, S. S., & Illum, L. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00376-5 · Cited by 146
Controlled release injectable liposomal gel of ibuprofen for epidural analgesia
Paavola, A., Kilpeläinen, I., Yliruusi, J., & Rosenberg, P. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00376-8 · Cited by 143
Koffi, A., Agnely, F., Ponchel, G., & Grossiord, J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.11.001 · Cited by 139
Self-citationWenzel, J. G. W., Balaji, K., Koushik, K., Navarre, C. B., Duran, S. H., Rahe, C. H., & Kompella, U. B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00271-7 · Cited by 139
Biological Activity of Urease Formulated in Poloxamer 407 after Intraperitoneal Injection in the Rat
Pec, E. A., Wout, Z. G., & Johnston, T. P. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810707 · Cited by 133
Poloxamer 407-induced atherogenesis in the C57BL/6 mouse
Palmer, W. K., Emeson, E. E., & Johnston, T. P. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00193-7 · Cited by 132
Morishita, M., Barichello, J. M., Takayama, K., et al. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00615-3 · Cited by 131
rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery
Kim, E. Y., Gao, Z.-G., Park, J., et al. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00933-4 · Cited by 129
Factors affecting the size distribution of liposomes produced by freeze–thaw extrusion
Castile, J. D., & Taylor, K. M. G. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00207-0 · Cited by 126
Effect of Water-Soluble Carriers on Dissolution Characteristics of Nifedipine Solid Dispersions
Chutimaworapan, S., Ritthidej, G. C., Yonemochi, E., Oguchi, T., & Yamamoto, K. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100100985 · Cited by 126
Bochot, A., Fattal, E., Gulik, A., et al. (1998) · Pharmaceutical Research · doi:10.1023/a:1011989202488 · Cited by 121
Controlled Release of Lidocaine from Injectable Gels and Efficacy in Rat Sciatic Nerve Block
Paavola, A., Yliruusi, J. K., Kajimoto, Y., et al. (1995) · Pharmaceutical Research · doi:10.1023/a:1016264527738 · Cited by 120
Rheological properties of poloxamer vehicles
Miller, S. C., & Drabik, B. R. (1984) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(84)90142-x · Cited by 118
Release Rates of Ketoprofen from Poloxamer Gels in a Membraneless Diffusion Cell
Chi, S. C., & Jun, H. W. (1991) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600800318 · Cited by 107
Toxicological evaluation of poloxamer vehicles for intramuscular use.
Johnston, T. P., & Miller, S. C. (1985) · PubMed · Cited by 107
Enhanced permeation of triamcinolone acetonide through the buccal mucosa
Shin, S., & Kim, J. Y. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00101-6 · Cited by 106
Anderson, B. C., Pandit, N. K., & Mallapragada, S. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00341-2 · Cited by 101
Pluronic Microemulsions as Nanoreservoirs for Extraction of Bupivacaine from Normal Saline
Varshney, M., Morey, T. E., Shah, D. O., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0394479 · Cited by 101
Rogers, T. L., Nelsen, A. C., Sarkari, M., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1022628826404 · Cited by 97
Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel
Blonder, J. M., Baird, L., Fulfs, J. C., & Rosenthal, G. J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00495-6 · Cited by 87
Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats
Shin, S.-C., Cho, C., & Oh, I.-J. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00339-7 · Cited by 86
Micellar solutions of triblock copolymer surfactants with pilocarpine
Pepić, I., Jalšenjak, N., & Jalšenjak, I. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.11.032 · Cited by 84
Anti-inflammatory Activity of Ketoprofen Gel on Carrageenan-Induced Paw Edema in Rats
Chi, S., & Jun, H. W. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600791106 · Cited by 84
Intratumoral Administration of Paclitaxel in an In Situ Gelling Poloxamer 407 Formulation
Amiji, M. M., Lai, P., Shenoy, D. B., & Rao, M. (2002) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120003487 · Cited by 84
Moghimi, S. M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00273-4 · Cited by 81
Desai, S. D., & Blanchard, J. D. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980222j · Cited by 80
Shin, S.-C., Kim, J.-Y., & Oh, I.-J. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100100358 · Cited by 80
Takahashi, A., Suzuki, S., Kawasaki, N., Kubo, W., Miyazaki, S., Löebenberg, R., BACHYNSKY, J. A., & Attwood, D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00394-0 · Cited by 79
Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels
Juhász, J., Lenaerts, V., Raymond, P., & Ong, H. (1989) · Biomaterials · doi:10.1016/0142-9612(89)90103-8 · Cited by 64
Rheological study of a thermoreversible morphine gel
Dumortier, G., Grossiord, J., Zuber, M., Couarraze, G., & Chaumeil, J. C. (1991) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049109043858 · Cited by 64
Self-citationNalbandian, R. M., Henry, R. L., & Wilks, H. S. (1972) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820060610 · Cited by 62
Neutrophil activation by plasma opsonized polymeric microspheres: inhibitory effect of Pluronic F127
Jackson, J. K., Springate, C. M. K., Hunter, W. L., & Burt, H. M. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00034-x · Cited by 60
Park, Y., Yong, C. S., Kim, H.-M., Rhee, J.-D., Oh, Y., Kim, C.-K., & Choi, H.-G. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00362-4 · Cited by 60
Rogers, T. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00193-5 · Cited by 57
Permeation of Piroxicam from the Poloxamer Gels
Shin, S.-C., Cho, C., & Choi, H. (1999) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102171 · Cited by 54
Bone Morphogenetic Protein Excipients: Comparative Observations on Poloxamer
Clokie, C. M. L., & Urist, M. R. (2000) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200002000-00023 · Cited by 53
A Novel Method for Viral Gene Delivery in Solid Tumors
Wang, Y., Liu, S., Li, C., & Yuan, F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1112 · Cited by 53
Evaluation of Pluronic Polyols as Carriers for Grafting Materials: Study in Rat Calvaria Defects
Fowler, E. B., Cuenin, M. F., Hokett, S. D., Peacock, M. E., McPherson, J. C., Dirksen, T. R., Sharawy, M., & Billman, M. A. (2002) · Journal of Periodontology · doi:10.1902/jop.2002.73.2.191 · Cited by 52
Enhanced stability of two model proteins in an agitated solution environment using poloxamer 407.
Wang, P.-L., & Johnston, T. P. (1993) · PubMed · Cited by 50
Lode, J., Fichtner, I., Kreuter, J., Berndt, A., Diederichs, J. E., & Reszka, R. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1013094801351 · Cited by 47
In Vitro Release Studies of Flurbiprofen from Different Topical Formulations
Gendy, A. M. E., Jun, H. W., & Kassem, A. A. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120005628 · Cited by 46
Saski, W., & Shah, S. G. (1965) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600540117 · Cited by 43
Sustained-release of urease from a poloxamer gel matrix.
Fults, K., & Johnston, T. P. (1990) · PubMed · Cited by 43
Regression of poloxamer 407-induced atherosclerotic lesions in C57BL/6 mice using atorvastatin
Johnston, T. P., Baker, J. C., Hall, D., Jamal, S., Palmer, W. K., & Emeson, E. E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00339-1 · Cited by 40
Castile, J. D., Taylor, K. M. G., & Buckton, G. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00685-8 · Cited by 39
Effects of Hyperlipidemia on the Pharmacokinetics of Nifedipine in the Rat
Eliot, L., Foster, R. T., & Jamali, F. (1999) · Pharmaceutical Research · doi:10.1023/a:1018896912889 · Cited by 38
Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix.
Johnston, T. P., & Miller, S. C. (1989) · PubMed · Cited by 37
Bourré, L., Thibaut, S., Briffaud, A., Lajat, Y., & Patrice, T. (2002) · Pharmacological Research · doi:10.1006/phrs.2001.0934 · Cited by 36
Development of Model Aqueous Ophthalmic Solution of Indomethacin
Dimitrova, E., Богданова, С. А., Mitcheva, M., et al. (2000) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-100102312 · Cited by 36
Chetoni, P., PANICHI, L., Burgalassi, S., Benelli, U., & Saettone, M. F. (2000) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2000.16.363 · Cited by 36
Johnston, T. P., Baker, J. C., Jamal, A. S., Hall, D., Emeson, E. E., & Palmer, W. K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00010 · Cited by 35
Moghimi, S. M. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00157-9 · Cited by 29
Investigation of the Utility of an In Vitro Release Test for Optimizing Semisolid Dosage Forms
Proniuk, S., Dixon, S. E., & Blanchard, J. D. (2001) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100002255 · Cited by 25
Interactions among proteins and hydrophobically modified polyelectrolytes
Bromberg, L. E. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775659 · Cited by 24
Micelle formation by oxyethylene-oxypropylene polymers.
Anderson, R. A. (1972) · PubMed · Cited by 23
Lu, G. W., Jun, H. W., Dzimianski, M. T., et al. (1995) · Pharmaceutical Research · doi:10.1023/a:1016231303689 · Cited by 21
Ramirez, R. J. J., Novák, J., Johnston, T. P., Gandley, R. E., McLaughlin, M. K., & Hubel, C. A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.4.r1330 · Cited by 21
Cited by
Thermoresponsive hydrogels in biomedical applications
Klouda, L., & Mikos, A. G. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.02.025 · Cited by 1,349
Hydrogels for Protein Delivery
Vermonden, T., Censi, R., & Hennink, W. E. (2012) · Chemical Reviews · doi:10.1021/cr200157d · Cited by 1,091
In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery
He, C., Kim, S. W., & Lee, D. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.005 · Cited by 867
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Chiappetta, D. A., & Sosnik, A. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.03.022 · Cited by 567
Metadata
- Authors
- Dumortier, G., Grossiord, J. L., Agnely, F., & Chaumeil, J. C.
- Venue
- Pharmaceutical Research
- Published
- 2006-11-11
- Volume
- 23
- Issue
- 12
- Pages
- 2709-2728
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1969604041
- Cited by
- 1,261
- References
- 88
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.